Abstract:Background and aims: Cognitive impairment is on the rise around the world, with profound economic and social consequences. Serum globulin, a marker of liver function, may also play a role in cognitive function. Unfortunately, no consistent conclusion exists regarding the association between serum globulin and cognitive function. Methods: Data from the 2011 to 2014 National Health and Nutrition Examination Survey were used to assess the association between serum globulin and cognitive impairment. Cognitive function was assessed by three tests: Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Animal Fluency (AF), and Digit Symbol Substitution Test (DSST). Furthermore, the breakthrough point of cognitive impairment correlated with CERAD < 5, AF < 14, and DSST < 34. A weighted multiple logistics regression model was used to verify the association between serum globulin and cognitive impairment. Generalized additive models (GAMs) and a smooth curve fit (penalty spline method) were used to determine a non-linear relationship between serum globulin and cognitive impairment. Finally, subgroup analysis and interaction tests were conducted to further verify the association between serum globulin and cognitive impairment. Results: Data from 2,768 participants aged ≥60 (in accordance with the study design) were collected for the final analysis. Data suggested that serum globulin levels were associated with an elevated cognitive impairment based on the AF [full adjustment, OR = 1.05, 95% CI: 1.01-1.08] and DSST [full adjustment, OR = 1.06, 95% CI: 1.02-1.10] tests. Eventually, the GAM and smooth curve fit model was conducted to confirm that the association between serum globulin and cognitive impairment was non-linear. Moreover, the inflection point was 27 g/L serum globulin based on the CERAD test and 35 g/L serum globulin based on the AF test. Finally, the interaction term between serum globulin and cognitive impairment based on the AF test indicated no significant interactions among all variables (all p for interaction >0.05). Conclusion: The association between serum globulin levels and cognitive impairment is non-linear. A threshold effect exists between serum globulin and cognitive impairment. Large-scale prospective clinical trials are needed to validate our findings.

Quantitation of Circulating GDF-11 and Β2-Mg in Aged Patients with Age-Related Impairment in Cognitive Function.

Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals

Glymphatic Function Plays a Protective Role in Ageing-Related Cognitive Decline

A Renewed Focus on GDF11 Level Fluctuation in Human Serum in Relation to Physical Examination Indicators

GDF11 Rejuvenates Neural Stem Cells Via Smad2/3-PI3K-AKT-mTOR and Reverses Aged-Dependent Cognitive Decline

Association Between Serum Β2-Microglobulin Levels and Frailty in an Elderly Chinese Population: Results from RuLAS

GDF15 as a biomarker of ageing

GDF-15 As a Biomarker of Aging

Macrophage Inhibitory Cytokine-1/Growth Differentiation Factor 15 As a Marker of Cognitive Ageing and Dementia

Associations of Serum GDF-15 Levels with Physical Performance, Mobility Disability, Cognition, Cardiovascular Disease, and Mortality in Older Adults

Associations of circulating GDF15 with combined cognitive frailty and depression in older adults of the MARK-AGE study

Serum Growth Differentiation Factor 11 is Closely Related to Metabolic Syndrome in a Chinese Cohort

Dietary Intake of GDF11 Delays the Onset of Several Biomarkers of Aging in Male Mice Through Anti-Oxidant System Via Smad2/3 Pathway.

Association between serum globulin and cognitive impairment in older American adults

Circulating Concentrations of Growth Differentiation Factor 11 Are Heritable and Correlate with Life Span.

Systemic GDF11 attenuates depression-like phenotype in aged mice via stimulation of neuronal autophagy

Administration of Rgdf11 Retards the Aging Process in Male Mice Via Action of Anti-Oxidant System.

The Relationships Between Plasma Advanced Glycation End Products Level and Cognitive Function in Middle-Aged and Elderly Chinese Subjects.

Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans

Biofluid GPNMB/osteoactivin as a potential biomarker of ageing: A cross-sectional study